In precision oncology, even the smallest specimen can shape critical clinical decisions. In this episode of Labcorp Perspectives: Oncology, Dr. Rebecca Previs speaks with Dr. Kyle Strickland and Dr. Erin Newburn about the essential—but often overlooked—role of tissue stewardship. They explore how pre-analytical choices, workflow design, and advancing technologies influence the quality and clinical value of molecular insights, and how clinicians, researchers, and biopharma partners can maximize limited samples without compromising patient care.
